SCHEMBL9264331

SCHEMBL9264331

O[C@@H]1CCCC[C@H]1Sc1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.46
TSHR P16473 2/20 0.46
NPC1 O15118 2/20 0.46
HTT P42858 2/20 0.41
HPGD P15428 2/20 0.36
CETP P11597 1/20 0.34
POLB P06746 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C19 P33261 2/20 0.33
TAS1R3 Q7RTX0 2/20 0.33
TAS1R1 Q7RTX1 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC18A3 Q16572 1/20 0.33
LDHA P00338 3/20 0.32
LDHB P07195 3/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9264336 1.00 RAB9A (0.46) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9264328 1.00 RAB9A (0.46) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9266079 0.81 TSHR (0.43) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9266070 0.81 TSHR (0.43) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9266076 0.81 TSHR (0.43) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9268606 0.80 TDP1 (0.46) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9268599 0.80 TDP1 (0.46) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9268602 0.80 TDP1 (0.46) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9261948 0.79 TSHR (0.46) RAB9ATSHRNPC1HTTHPGD
SCHEMBL9261943 0.79 TSHR (0.46) RAB9ATSHRNPC1HTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5476944-A Inhibitors or stimulators of superoxide generation; may also inhibit cyclooxygenase and/or 5-lipoxygenase; useful in therapeutic or prophylactic treatment of disease conditions G. D. SEARLE & CO. (US) 1995-12-19 US disclosed
EP-0613463-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1994-09-07 EP disclosed
WO-1993010087-A1 DERIVATIVES OF CYCLIC PHENOLIC THIOETHERS AS INHIBITORS OR STIMULATORS OF SUPEROXIDE GENERATION G.D. SEARLE & CO. (US) 1993-05-27 WO disclosed